The Global Health Body Sounds Concern Over Critical Shortage of Weight-Loss Jabs
Fewer than a tenth of patients who could benefit from obesity jabs such as Wegovy are able to get them, warns the World Health Organization as it issues its inaugural advice on the therapies.
Given in excess of 1,000,000,000 people worldwide now living with obesity, it is advocating for more widespread and fairer access to these injectable treatments.
Based on estimates, more than two billion could be obese by 2030 unless action is taken.
"The latest guidance recognises that excess weight is a lifelong illness that can be managed with comprehensive and lifelong care," stated WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, limited production capacity, and supply-chain constraints are significant obstacles to widespread availability to the injections that can aid individuals in losing significant weight, explains the organization.
Skinny Jab Scarcity
Even under the present best projected outlook, the production of GLP-1 therapies might only reach about 100 million people – less than 10% of those who need them, per the WHO.
The recommendation calls on nations and manufacturers to expand access, through measures such as licensing agreements.
Exclusive production rights on the active ingredient – the core ingredient of the drug Wegovy – is due to expire in multiple countries in 2026.
How Weight-Loss Jabs Work
The injections mimick a natural hormone to reduce digestion speed, suppress the appetite and enhance feelings of fullness so individuals eat less.
Patients usually begin shedding pounds within a few weeks of beginning the once-weekly jabs.
Evidence suggests people may regain a significant portion within a year of discontinuing the treatment, when their usual hunger come back.
To be carrying excess weight raises your chance for developing medical conditions, including type 2 diabetes, heart disease, brain attack, and some cancers.
Excess weight impacts people in every country and was responsible for 3.7 million fatalities worldwide in 2024, as per the health agency.
